You are here: Industry Insights > WOCKHARDT

News List

Wockhardt’s bioequivalence centre at Aurangabad receives zero observations from US FDA expressbpd
June 14, 2019
During the inspection, bioanalytical and quality systems of bioequivalence studies of Tamsulosin 0.4 mg capsules and Metoprolol ER tablets were audited
Wockhardt receives US FDA approval for leukemia drug expressbpd
January 22, 2019
The drug stops cancer cells from growing and is indicated for treating cancers like leukemia and some gastro-intestinal tumors
Wockhardt Q2 net loss widens to ₹ 23 crore expressbpd
November 10, 2018
The company, which plans to raise up to ₹ 1,800 crore through private placement of non-convertible debentures, had reported a consolidated net loss of ₹ 3 crore in the same quarter of the previous fiscal.
Wockhardt builds $40M plant in Dubai to produce ‘superbug’ fighters fiercepharma
July 31, 2018
India’s Wockhardt is working to develop antimicrobial drugs to fight the emerging threat of superbugs, and the company has built a $40 million manufacturing facility in Dubai to produce them.
Wockhardt launches $40m manufacturing plant in Dubai pharmafile
July 31, 2018
Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, the new site will focus on the manufacture of New Chemical Entities (NCEs) to global markets; in particular, it
Wockhardt bags US FDA approval for antibiotic injection expressbpd
August 08, 2017
Oxacillin, a penicillinase-resistant beta-lactam antibiotic, will be launched in the US soon
Wockhardt receives US FDA approval for Olopatadine HCI financialexpress
July 04, 2017
Olopatadine HCI, eye drop to treat ophthalmic allergies, is a generic version of Patanol
Wockhardt receives US FDA approval for Olopatadine HCI receives US FDA approval for Olopatadine HCI expressbpd
July 04, 2017
Olopatadine HCI, eye drop to treat ophthalmic allergies, is a generic version of Patanol
Wockhardt seeks shareholders’ nod to raise Rs 1,000 cr financialexpress
May 08, 2017
The shareholders can approve the resolution through e-voting or physical postal ballot form

Previous page 1 2 Next page